GZMB

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

(Redirected from Granzyme B)
Jump to: navigation, search


Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
PDB rendering based on 1fq3.
Identifiers
Symbol(s) GZMB; HLP; CTLA1; CCPI; CGL-1; CGL1; CSP-B; CSPB; CTSGL1; SECT
External IDs OMIM: 123910 MGI109267 Homologene20876
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 3002 14939
Ensembl ENSG00000100453 ENSMUSG00000015437
Uniprot P10144 Q3TIP3
Refseq NM_004131 (mRNA)
NP_004122 (protein)
NM_013542 (mRNA)
NP_038570 (protein)
Location Chr 14: 24.17 - 24.17 Mb Chr 14: 55.21 - 55.22 Mb
Pubmed search [1] [2]

WikiDoc Resources for

GZMB

Articles

Most recent articles on GZMB

Most cited articles on GZMB

Review articles on GZMB

Articles on GZMB in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on GZMB

Images of GZMB

Photos of GZMB

Podcasts & MP3s on GZMB

Videos on GZMB

Evidence Based Medicine

Cochrane Collaboration on GZMB

Bandolier on GZMB

TRIP on GZMB

Clinical Trials

Ongoing Trials on GZMB at Clinical Trials.gov

Trial results on GZMB

Clinical Trials on GZMB at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on GZMB

NICE Guidance on GZMB

NHS PRODIGY Guidance

FDA on GZMB

CDC on GZMB

Books

Books on GZMB

News

GZMB in the news

Be alerted to news on GZMB

News trends on GZMB

Commentary

Blogs on GZMB

Definitions

Definitions of GZMB

Patient Resources / Community

Patient resources on GZMB

Discussion groups on GZMB

Patient Handouts on GZMB

Directions to Hospitals Treating GZMB

Risk calculators and risk factors for GZMB

Healthcare Provider Resources

Symptoms of GZMB

Causes & Risk Factors for GZMB

Diagnostic studies for GZMB

Treatment of GZMB

Continuing Medical Education (CME)

CME Programs on GZMB

International

GZMB en Espanol

GZMB en Francais

Business

GZMB in the Marketplace

Patents on GZMB

Experimental / Informatics

List of terms related to GZMB

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3] Phone:617-632-7753

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [4] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1), also known as GZMB, is a human gene.


Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein encoded by this gene is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response.[1]


See also

References

Further reading

  • Trapani JA (1996). "Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perforin, and the serine protease, granzyme B.". Australian and New Zealand journal of medicine 25 (6): 793-9. PMID 8770355.
  • Cohen GM (1997). "Caspases: the executioners of apoptosis.". Biochem. J. 326 ( Pt 1): 1-16. PMID 9337844.
  • Trapani JA, Sutton VR (2004). "Granzyme B: pro-apoptotic, antiviral and antitumor functions.". Curr. Opin. Immunol. 15 (5): 533-43. PMID 14499262.



WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools
related articles